Investigação, Desenvolvimento e Inovação · Em Execução

Pensos 3D vivos e activos customizados para feridas crónicas

FARM-ID - ASSOCIAÇÃO DA FACULDADE DE FARMÁCIA PARA A INVESTIGAÇÃO E DESENVOLVIMENTO

Fundo aprovado
80 490,24 €
Fundo executado
0,00 €
Fundo pago
8 049,02 €

Esta ficha organiza os campos que o Portugal 2030 publica sobre a operação: financiamento aprovado, execução administrativa, enquadramento e território. O mérito da candidatura e os resultados no terreno não constam desta fonte.

LISBOA2030-FEDER-00711700

O QUE FOI APRESENTADO

Finalidade da operação

The project aims the development of customized WD by engineering 3D-printed multifunctional hydrogels for wound healing. Specifically, by joining the suitable properties of a regenerative hydrogel with the incorporation of live microalgae for oxygen production, healing will be assured, and then depending on each patient’s needs this regenerative platform will be customized with different therapeutic agent formulations (i.e. antimicrobial nanoparticles, debridement enzymes) assuring a therapeutic platform not prone to the development of resistance. i) The proposed research addresses the following important challenges: a) Complexity of chronic wound management b) Achievement of a healing WD platform suitable for different patients and wounds c) Achievement of different nano-delivery systems…

Ler a descrição publicada na íntegra

The project aims the development of customized WD by engineering 3D-printed multifunctional hydrogels for wound healing. Specifically, by joining the suitable properties of a regenerative hydrogel with the incorporation of live microalgae for oxygen production, healing will be assured, and then depending on each patient’s needs this regenerative platform will be customized with different therapeutic agent formulations (i.e. antimicrobial nanoparticles, debridement enzymes) assuring a therapeutic platform not prone to the development of resistance. i) The proposed research addresses the following important challenges: a) Complexity of chronic wound management b) Achievement of a healing WD platform suitable for different patients and wounds c) Achievement of different nano-delivery systems regarding different therapeutic needs and thus WD customization. d) Selection of antimicrobial agents not prone to the development of resistance (due to their mechanism of action). ii) The proposed objectives are beyond the state of the art due to: a) Use of emergent approaches (3D-printing, Artificial Intelligence tools, nanotechnology, biotech) to ensure the quality of the final product; b) Combination of the advantages of different eco-friendly medical grade polymers, antimicrobials not prone to the development of resistance (e.g., biosurfactants, antiseptics) and/or, debridement enzymes in nano-delivery systems in one single 3D-structure; b) Multi-functionalization of the 3D-hydrogel with regenerative and oxygen-producing components (hyaluronic acid and microalgae, respectively); c) Functionalize/load the 3D-regenerative platform with customized hydrogels loaded with the produced nanoparticles regarding the need for specific drugs and doses; d) Conduct a multidisciplinary approach to select the 3D-printed WD with an optimal regenerative, therapeutic activity and biosafety profile. e) Establish advanced in vitro test systems for 3D printed WDs to select the ones with a suitable regenerative, antibacterial, and biosafety profile; f) Gather a multidisciplinary team from different research areas, clinicians, and industry focusing on solving chronic wound challenges and implementing new innovative trends in chronic wound management. Overall, 3D-Alive&Active-WD represents a groundbreaking endeavor to revolutionize wound care by engineering of customized wound dressings. The project novelty lies in combining the unique attributes of regenerative hydrogels with live microalgae for oxygen generation, and antimicrobial nanoparticles not prone to induce resistance ensuring robust healing outcomes and therapeutic.

PROGRAMA E OBJETIVOS

Como a operação está enquadrada

Programa
Programa Regional de Lisboa
Fundo
Fundo Europeu de Desenvolvimento Regional
Objetivo estratégico
+ Inteligente
Objetivo específico
Reforçar a investigação, inovação e adoção de tecnologias avançadas.
Área temática
Investigação, Desenvolvimento e Inovação
Atividade económica
Outra investigação e desenvolvimento das ciências físicas e naturais
Modalidade
Subvenção
Taxa de cofinanciamento
40%

ONDE

Distribuição territorial publicada

LisboaÁrea Metropolitana de Lisboa · Área Metropolitana de Lisboa
100% da localização

Localização observada no ficheiro de 31 de agosto de 2026.

QUANDO

Calendário publicado

Início previsto
1 de julho de 2025
Início efetivo
29 de setembro de 2025
Conclusão prevista
29 de junho de 2028
Conclusão efetiva
Não indicada

PROVENIÊNCIA

Fonte oficial e datas de corte

Operação e valores: 31 de agosto de 2026. Localização: 31 de agosto de 2026.

Consultar o portal oficial Portugal 2030 ↗Capturas validadas por SHA-256; fonte verificada em 21 de setembro de 2026.
Pensos 3D vivos e activos customizados para feridas crónicas | Impacto Público